TWD 49.65
(-0.2%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 4.05 Billion TWD | 213.55% |
2022 | 1.29 Billion TWD | -39.6% |
2021 | 2.13 Billion TWD | -17.39% |
2020 | 2.58 Billion TWD | -14.59% |
2019 | 3.03 Billion TWD | 10.14% |
2018 | 2.75 Billion TWD | 5.81% |
2017 | 2.6 Billion TWD | 29.66% |
2016 | 2 Billion TWD | -48.23% |
2015 | 3.87 Billion TWD | 33.04% |
2014 | 2.91 Billion TWD | 29.61% |
2013 | 2.24 Billion TWD | -7.64% |
2012 | 2.43 Billion TWD | 39.98% |
2011 | 1.73 Billion TWD | -12.43% |
2010 | 1.98 Billion TWD | -30.0% |
2009 | 2.83 Billion TWD | 117.41% |
2008 | 1.3 Billion TWD | 52.5% |
2007 | 855.29 Million TWD | -0.14% |
2006 | 856.48 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 357.21 Million TWD | 25.41% |
2024 Q2 | 522.12 Million TWD | 46.17% |
2023 Q4 | 284.82 Million TWD | -45.0% |
2023 FY | 4.05 Billion TWD | 213.55% |
2023 Q1 | 267.71 Million TWD | -56.33% |
2023 Q2 | 3.03 Billion TWD | 1032.26% |
2023 Q3 | 517.83 Million TWD | -82.92% |
2022 Q1 | 286.39 Million TWD | -0.61% |
2022 FY | 1.29 Billion TWD | -39.6% |
2022 Q4 | 613.1 Million TWD | 78.69% |
2022 Q3 | 343.1 Million TWD | 594.15% |
2022 Q2 | 49.42 Million TWD | -82.74% |
2021 Q3 | 508.47 Million TWD | -21.28% |
2021 Q2 | 645.9 Million TWD | -7.26% |
2021 FY | 2.13 Billion TWD | -17.39% |
2021 Q1 | 696.44 Million TWD | 14.35% |
2021 Q4 | 288.15 Million TWD | -43.33% |
2020 Q3 | 682.27 Million TWD | 6.43% |
2020 Q4 | 609.05 Million TWD | -10.73% |
2020 Q1 | 656.75 Million TWD | -38.26% |
2020 Q2 | 641.03 Million TWD | -2.39% |
2020 FY | 2.58 Billion TWD | -14.59% |
2019 Q1 | 614.85 Million TWD | -11.14% |
2019 Q3 | 681.17 Million TWD | 1.43% |
2019 Q4 | 1.06 Billion TWD | 56.16% |
2019 FY | 3.03 Billion TWD | 10.14% |
2019 Q2 | 671.54 Million TWD | 9.22% |
2018 Q2 | 685.58 Million TWD | 2.59% |
2018 Q4 | 691.93 Million TWD | -2.07% |
2018 FY | 2.75 Billion TWD | 5.81% |
2018 Q1 | 668.24 Million TWD | 9.96% |
2018 Q3 | 706.59 Million TWD | 3.06% |
2017 Q1 | 710.86 Million TWD | 23.21% |
2017 FY | 2.6 Billion TWD | 29.66% |
2017 Q4 | 607.73 Million TWD | -9.13% |
2017 Q3 | 668.8 Million TWD | 8.96% |
2017 Q2 | 613.81 Million TWD | -13.65% |
2016 Q1 | 453.2 Million TWD | -71.97% |
2016 FY | 2 Billion TWD | -48.23% |
2016 Q2 | 436.62 Million TWD | -3.66% |
2016 Q3 | 539.47 Million TWD | 23.56% |
2016 Q4 | 576.94 Million TWD | 6.95% |
2015 Q1 | 339.35 Million TWD | -88.55% |
2015 FY | 3.87 Billion TWD | 33.04% |
2015 Q4 | 1.61 Billion TWD | 55.25% |
2015 Q3 | 1.04 Billion TWD | 18.74% |
2015 Q2 | 877.16 Million TWD | 158.48% |
2014 Q3 | -35.21 Million TWD | -1151.28% |
2014 FY | 2.91 Billion TWD | 29.61% |
2014 Q1 | -18.1 Million TWD | -169.55% |
2014 Q2 | 3.35 Million TWD | 118.5% |
2014 Q4 | 2.96 Billion TWD | 8512.19% |
2013 Q3 | 140.96 Million TWD | -46.85% |
2013 Q4 | 26.03 Million TWD | -81.53% |
2013 Q1 | 1.81 Billion TWD | 16.4% |
2013 Q2 | 265.23 Million TWD | -85.39% |
2013 FY | 2.24 Billion TWD | -7.64% |
2012 Q4 | 1.55 Billion TWD | 270.62% |
2012 FY | 2.43 Billion TWD | 39.98% |
2012 Q1 | 162.04 Million TWD | -19.71% |
2012 Q2 | 291.07 Million TWD | 79.63% |
2012 Q3 | 420.71 Million TWD | 44.54% |
2011 Q2 | 516.74 Million TWD | -14.86% |
2011 FY | 1.73 Billion TWD | -12.43% |
2011 Q4 | 201.82 Million TWD | -51.1% |
2011 Q3 | 412.69 Million TWD | -20.14% |
2011 Q1 | 606.96 Million TWD | 14.83% |
2010 FY | 1.98 Billion TWD | -30.0% |
2010 Q4 | 528.58 Million TWD | 8.31% |
2010 Q3 | 488 Million TWD | -12.43% |
2010 Q2 | 557.25 Million TWD | 35.54% |
2010 Q1 | 411.12 Million TWD | 0.0% |
2009 FY | 2.83 Billion TWD | 117.41% |
2008 FY | 1.3 Billion TWD | 52.5% |
2007 FY | 855.29 Million TWD | -0.14% |
2006 FY | 856.48 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Sinon Corporation | 5.19 Billion TWD | 22.085% |
All Cosmos Bio-Tech Holding Corporation | 565.88 Million TWD | -615.913% |
CH Biotech R&D Co., Ltd. | 1.26 Billion TWD | -221.502% |